Abstract: Systems and methods support secure transfer of data between workspaces operating on an IHS (Information Handling System). Upon a request for access to a first managed resource, such as protected data, a first workspace is deployed according to a first workspace definition. Upon a request for access to a second managed resource, a second workspace is deployed according to a second workspace definition. In response to an indication of a portion of the protected data from the first workspace being copied to a buffer supported by the IHS and of a request to paste the copied portion of the protected data to the second workspace, the protections provided by the second workspace are evaluated. If the protections of the second workspace are inadequate, an updated second workspace definition is selected that specifies additional protections. The second workspace is updated according to the updated second workspace definition and the transfer is permitted.

Abstract: Systems and methods provide multilevel authorization of workspaces using certificates, where all of the authorization levels may be authorized separately or may instead be authorized at once. A measurement of an IHS (Information Handling System) is calculated based on the identity of the IHS and based on firmware of the IHS. A measurement of the configuration of the IHS is calculated based on information for configuring the IHS for supporting workspaces and also based on the IHS measurement. A measurement of a workspace session is calculated based on properties of a session used to remotely support operation of the workspace by the IHS and also based on the configuration measurement. Workspace session data may by authorized at all three levels by evaluating the session measurement against a reference session measurement.

Abstract: The present invention relates to Compounds of Formula I and Ia and pharmaceutically acceptable salts or prodrug thereof, wherein R1, R2, X, A and B are as defined herein. The present invention also relates to compositions comprising at least one compound of Formula I or Ia, and methods of using the compounds of Formula I or Ia for treating or preventing HIV infection in a subject.

Abstract: An information handling system operating an enterprise endpoint embedded subscriber identification module (eSIM) provisioning system may comprise a processor, memory, and network interface device for transceiving data with an endpoint computing device having an embedded universal integrated circuit card (eUICC) capable of programmable selection among networks including at least one network in a 5G New Radio frequency band, the processor executing code of an enterprise client management (ECM) system for management of eSIM profiles for plural endpoint computing devices, the ECM system associating a unique hardware derived device IDentification based on hardware components of the endpoint computing device with a level of wireless service for the endpoint computing device based on enterprise allocation of service for the endpoint computing device via the ECM system, and the network interface device transmitting an eSIM profile to the endpoint computing device for implementation at the eUICC for the assigned level

Abstract: Methods and system are provided for dynamically securing a workspace based on changes in the security context in which the workspace operates. Upon receiving a request from an IHS for access to a managed resource and receiving attributes of a risk context for the request, a risk score for the request is determined. A workspace definition that provides access to the managed resource is selected based on the risk score. A workspace definition includes security requirements for operation of the workspace by the IHS, where the security requirements are commensurate with the risk score. The workspace definition is transmitted to the IHS for operation of the workspace according to the security requirements. A risk context may include, IHS software, a physical environment in which the IHS is located, a physical location of the IHS, a classification of the requested resource, IHS hardware, and a user of the IHS.

Abstract: An information handling system of a Radio Access Network (RAN) system operating a secure network slice orchestration system may comprise a network interface device of the RAN system transceiving data within a 5G New Radio (NR) frequency band with an endpoint computing device, the network interface device receiving an instruction from a client solutions management (CSM) platform to assign a network slice within the 5G NR frequency band, based on a security profile associating the endpoint computing device with a security tier, to a network slice as established by a software defined network (SDN) controller within a sub-portion of the 5G NR frequency band, the secure network slice orchestration system determining the endpoint computing device is associated with the network slice within a communications profile received from the CSM platform, and the SDN controller establishing a virtual access point transceiving data within the network slice with the endpoint computing device.

Abstract: A disclosed method for provisioning a computing device includes receiving, by provisioning software that executes on the computing device to provision the computing device for access to an enterprise infrastructure from a device orchestration service through which computing devices are provisioned to access the enterprise infrastructure, a digital certificate representing a credential for accessing, by a user via the computing device, the enterprise infrastructure.

Abstract: Systems and methods for modernizing workspace and hardware lifecycle management in an enterprise productivity ecosystem are described. In some embodiments, a client Information Handling System (IHS) may include a processor and a memory, the memory having program instructions that, upon execution by the processor, cause the client IHS to: receive, from a workspace orchestration service, one or more files or policies configured to enable the client IHS to instantiate a first workspace based upon a first workspace definition; allow a user to execute a non-vetted application in the first workspace; determine that the first workspace is compromised; and receive, in response to the determination, from the workspace orchestration service, one or more other files or policies configured to enable the client IHS to instantiate a second workspace based upon a second workspace definition, where the second workspace definition allows execution of a vetted application corresponding to the non-vetted application.

Abstract: The present invention relates to Compounds of Formula I and pharmaceutically acceptable salts or prodrug thereof, wherein R1, R2, R3, R4, X and A are as defined herein. The present invention also relates to compositions comprising at least one compound of Formula I, and methods of using the compounds of Formula I for treating or preventing HIV infection in a subject.

Abstract: A low-power image sensor includes a plurality of light-sensitive pixel cells, a plurality of analog-to-digital converters (ADCs) and image processing circuitry. The image sensor can be disposed in multiple semiconductor layers such that the pixel cells are disposed in a first layer and various other components are disposed in the second layer or between the first layer and the second layer. The image sensor is configured such that the analog output of a pixel cell is sampled by a first ADC and a second ADC within respective first and second dynamic ranges, the second dynamic range being greater than the first dynamic range. The first ADC and the second ADC sample the analog output with different sampling resolutions. The digital outputs of the first ADC and the second ADC are subsequently used by an image processor to generate a pixel value for an image frame.

Abstract: The present invention discloses oxazolidinone compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein A and E, are as defined herein. The present invention also relates to compositions which comprise at least one oxazolidinone compound of the invention. The invention also provides methods for inhibiting growth of mycobacterial cells as well as a method of treating mycobacterial infections by Mycobacterium tuberculosis comprising administering a therapeutically effective amount of an oxazolidinone of the invention and/or a pharmaceutically acceptable salt thereof, or a composition comprising such compound and/or salt.

Abstract: A management system manages a plurality of information handling systems by creating custom policies for each information handling system based on information gathered from or about each information handling system indicating, e.g., the user's intent, use, request for usage, security posture, productivity needs, and/or behavior. The management system creates custom policies to avoid unnecessarily impacting a user's productivity.

Abstract: Systems and methods for modernizing workspace and hardware lifecycle management in an enterprise productivity ecosystem are described. In some embodiments, a client Information Handling System (IHS) may include a processor and a memory, the memory having program instructions that, upon execution by the processor, cause the client IHS to: receive, from a workspace orchestration service, one or more files or policies configured to enable the client IHS to instantiate a first workspace based upon a first workspace definition; allow a user to execute a non-vetted application in the first workspace; determine that the first workspace is compromised; and receive, in response to the determination, from the workspace orchestration service, one or more other files or policies configured to enable the client IHS to instantiate a second workspace based upon a second workspace definition, where the second workspace definition allows execution of a vetted application corresponding to the non-vetted application.

Abstract: The present invention relates to Compounds of Formula I: and pharmaceutically acceptable salts or prodrug thereof, wherein R1, R2, R3, R4 and A are as defined herein. The present invention also relates to compositions comprising at least one compound of Formula I, and methods of using the compounds of Formula I for treating or preventing HIV infection in a subject.

Abstract: Disclosed herein are compounds of formula (I) which are inhibitors of an IDO enzyme: (I). Also disclosed herein are uses of the compounds in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising these compounds. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.

Abstract: Disclosed herein are compounds of formula (I) which are inhibitors of an IDO enzyme: Also disclosed herein are uses of the compounds in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising these compounds. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.

Abstract: A system for configuring a processor is disclosed that includes a processor, a memory, and a firmware startup algorithm stored in the memory at a first predetermined location, the firmware start-up algorithm has one or more user-configurable driver algorithm memory storage locations. A driver algorithm stored at one of the user-configurable driver algorithm memory storage locations is configured to modify an operating system memory storage location for use by the firmware startup algorithm.

Abstract: The present invention relates to Compounds of Formula (I): Formula (I) and pharmaceutically acceptable salts or prodrug thereof, wherein R1, R2, R3, Ra, Rb, A and B are as defined herein. The present invention also relates to compositions comprising at least one compound of Formula (I), and methods of using the compounds of Formula (I) for treating or preventing HIV infection in a subject.

Abstract: An endpoint computing device dynamic network slice utilization system includes a core network system that is coupled to a RAN system and that is configured to allocate network slices and make them available for use in wireless communications via the RAN system. An endpoint computing device that includes an application operates to determine changing networking connectivity requirement for the application and/or the changing network characteristics of network slices during an application session, identify different network slices with networking characteristics that satisfy the changing networking connectivity requirements for the application, establish connection(s) for the application with those network slices, and exchange communications via the RAN system and the core network system for the application during the application session using the respective connection(s) established for the application with the respective network slices as the networking connectivity requirement for the application changes.

Abstract: A secure boot violation system includes a BIOS with an authenticated variables storage storing at least one authorization key and at least one signatures database. The BIOS receives a first policy action entry for association with a first signature in the at least one signatures database, determines that the first policy action entry is signed with the at least one authorization key and, in response, associates the first policy action entry with the first signature in the at least one signatures database. The BIOS then determines, during a boot process and subsequent to the associating the first policy action entry with the first signature, that a first secure boot violation has occurred based on the first signature in the at least one signatures database. In response to determining that the first secure boot violation has occurred, the BIOS performs a first policy action defined by the first policy action entry.